SinusPharma starts sinusitis Phase II

SinusPharma (Carpinteria, Calif.) began a double-blind, placebo-controlled, U.S. Phase II trial of its SPRC-AB01 antibiotic for nasal inhalation to treat chronic rhinosinusitis. The primary endpoint o...